Biomarkers of Cisplatin Resistance in Urothelial Bladder Cancer: HMGA2 and Survivin

被引：0
|
作者：
Reis, Henning [1 ]
Krafft, Ulrich [1 ]
Tschirdewahn, Stephan [1 ]
Hess, Jochen [1 ]
Harke, Nina [1 ]
Hadaschik, Boris [2 ]
Krege, Susanne [3 ]
Nyirady, Peter [4 ]
Szendroi, Attila [4 ]
Szucs, Miklos [4 ]
Modos, Orsolya [5 ]
Szekely, Eszter [6 ]
Szarvas, Tibor [1 ,4 ]
Szarvas, Tibor [1 ,4 ]
机构：
[1] Univ Duisburg Essen, West German Canc Ctr, Essen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany
[3] Kliniken Essen Mitte, Essen, Germany
[4] Semmelweis Univ, Budapest, Hungary
[5] Semmelweis Univ, Clin Urol, Budapest, BP, Hungary
[6] Semmelweis Univ, Univ Hosp Budapest, Budapest, Hungary
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
938
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HMGA2 expression in a canine model of prostate cancer
    Winkler, Susanne
    Escobar, Hugo Murua
    Meyer, Britta
    Simon, Daniela
    Eberle, Nina
    Baumgartner, Wolfgang
    Loeschke, Siegfried
    Nolte, Ingo
    Bullerdiek, Joern
    CANCER GENETICS AND CYTOGENETICS, 2007, 177 (02) : 98 - 102
  • [22] The emerging role and mechanism of HMGA2 in breast cancer
    Ma, Qing
    Ye, Sisi
    Liu, Hong
    Zhao, Yu
    Zhang, Wei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [23] HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA
    Yan, Jun
    Dai, Peng
    Qin, Xueliang
    He, Yanping
    Zhang, Yu
    MOLECULAR MEDICINE REPORTS, 2022, 25 (02)
  • [24] Urothelial bladder cancer: biomarkers for detection and screening
    Konety, Badrinath
    Lotan, Yair
    BJU INTERNATIONAL, 2008, 102 (09) : 1234 - 1241
  • [25] Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
    Humayun-Zakaria, Nada
    Arnold, Roland
    Goel, Anshita
    Ward, Douglas
    Savill, Stuart
    Bryan, Richard T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):
  • [26] COMBINED SILENCING OF SURVIVIN AND HMGA2 ONCOGENES ACHIEVES SYNERGISTIC EFFECTS IN INHIBITING COLON CANCER CELL GROWTH IN VITRO
    Wang, P.
    Dong, J. H.
    Wang, S. X.
    Liu, X. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 9 - 9
  • [27] HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer
    Jun, Kyong-Hwa
    Jung, Ji-Han
    Choi, Hyun-Joo
    Shin, Eun-Young
    Chin, Hyung-Min
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 24 : 39 - 44
  • [28] miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
    Zhijiao Song
    Caihe Liao
    Liqun Yao
    Xuexiang Xu
    Xuezhen Shen
    Siqi Tian
    Shuo Wang
    Feng Xing
    Cancer Gene Therapy, 2023, 30 : 596 - 607
  • [29] miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
    Song, Zhijiao
    Liao, Caihe
    Yao, Liqun
    Xu, Xuexiang
    Shen, Xuezhen
    Tian, Siqi
    Wang, Shuo
    Xing, Feng
    CANCER GENE THERAPY, 2023, 30 (04) : 596 - 607
  • [30] HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion
    Ros, Gloria
    Pegoraro, Silvia
    De Angelis, Paolo
    Sgarra, Riccardo
    Zucchelli, Silvia
    Gustincich, Stefano
    Manfioletti, Guidalberto
    FRONTIERS IN ONCOLOGY, 2020, 9
12345